Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy

Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in-utero - ScienceDirect

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Clearer Perspective on Genetics in IBD; Risankizumab for Treating

Treatment Strategies in Inflammatory Bowel Diseases (10.11.2023)

JCM, Free Full-Text

Ustekinumab in Dermatology: Approved Indications and Off-label Uses

Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease - ScienceDirect

Joost PH Drenth on X: Observational data from the adalimumab #PYRAMID registry of pregnant Crohn's disease patients @uegjournal ✓2⃣9⃣3⃣ pregnancies in #crohnsdisease ✓Biological therapy with #adalimumab 📌No adverse pregnancy outcomes @my_ueg

Vincent S. Panella on LinkedIn: Registry-Data-Show-Vedolizumab

PDF) Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn's Disease Treated Until 33 Weeks of Gestation

Crohn's disease and clinical management today: How it does?

View of Inflammatory bowel disease and pregnancy: fertility, complications and treatment

Treatment Persistence Of Ustekinumab In Crohn's Disease

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study - ScienceDirect

Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy